5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 256.75▲ | 257.02▼ | 257.23▼ | 257.09▼ | 259.13▼ |
MA10 | 256.91▲ | 257.37▼ | 257.60▼ | 257.25▼ | 262.90▼ |
MA20 | 256.95▲ | 257.48▼ | 257.42▼ | 258.72▼ | 277.14▼ |
MA50 | 257.24▼ | 257.28▼ | 257.23▼ | 264.34▼ | 281.99▼ |
MA100 | 257.52▼ | 257.51▼ | 257.08▼ | 279.63▼ | 251.05▲ |
MA200 | 257.40▼ | 257.27▼ | 260.83▼ | 280.71▼ | 271.07▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.009▲ | -0.132▼ | -0.112▼ | 0.444▲ | -2.986▼ |
RSI | 49.864▼ | 46.732▼ | 47.943▼ | 42.449▼ | 39.543▼ |
STOCH | 58.762 | 18.722▼ | 39.798 | 49.600 | 18.726▼ |
WILL %R | -16.935▲ | -67.559 | -67.559 | -51.458 | -85.566▼ |
CCI | -42.962 | -115.991▼ | -136.184▼ | 18.304 | -107.918▼ |
MA | $BIIB Price Crossed Below MA(7) | Set Alert |
Friday, September 29, 2023 01:25 PM
Sept. 29, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced that the U.S. Food and Drug Administration (FDA) has approved TOFIDENCE (tocilizumab-bavi) intravenous formulation, a biosimilar ...
|
Friday, September 29, 2023 01:09 PM
Sept. 29, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced that the U.S. Food and Drug Administration (FDA) has approved TOFIDENCE (tocilizumab-bavi) intravenous formulation, a biosimilar ...
|
Friday, September 29, 2023 09:00 AM
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
29/09/23 | 257.58 | 259.23 | 256.26 | 257.01 | 873,000 |
28/09/23 | 258.48 | 259.35 | 256.25 | 257.83 | 631,610 |
27/09/23 | 258.44 | 261.38 | 255.16 | 257.52 | 803,520 |
26/09/23 | 254.97 | 258.46 | 254.04 | 258.05 | 842,670 |
25/09/23 | 257.10 | 257.10 | 251.85 | 255.02 | 737,100 |
22/09/23 | 259.33 | 260.715 | 257.14 | 257.68 | 784,354 |
21/09/23 | 258.80 | 260.27 | 256.77 | 258.93 | 974,600 |
20/09/23 | 257.32 | 262.48 | 256.42 | 260.53 | 1,143,100 |
19/09/23 | 253.66 | 256.80 | 253.33 | 256.67 | 567,000 |
18/09/23 | 254.94 | 256.05 | 252.62 | 253.30 | 509,800 |
|
|
||||
|
|
||||
|
|